The Challenge of Change - Managing Excipients Control
Colorcon
CPhI Worldwide 2008 in Frankfurt, Germany
From emerging market trends to new product launches, this year's CPhI Worldwide in Frankfurt, Germany had something for everyone interested in the drug industry. Our reporting team spoke with all the key players to keep you up to date with all the hot topics.
Reaxa showcases Ni EnCat technology
Reaxa CEO Dr Peter Jackson explains why the firm added a nickel catalyst to its EnCat range.
Cargill talks about its excipient portfolio
Cargill discusses its C*PharmDex and Zerose Erythritol excipients at this year's CPhI in Frankfurt, Germany.
SAFC talks continuous processing
SAFC's Mike Harris explains bench top continuous processing at this year's CPhI
Cognis talks excipients
Dr Thomas Rosen discusses Cognis' new excipient TPGS, a water soluble form of vitamin E, and its applications in increasing bioavailability.
EFCG talks excipient certification
Tim Bölke, head of the excipient taskforce at the European Fine Chemicals Group, discusses certification and the heparin scandal.
SAFC showcases HPAPI handling capabilities
SAFC's Mike Harris sets out the firm's role in the expanding high-potency active pharmaceutical ingredient (HPAPI) industry.
Clarifying the benefits of sonocrystallisation
David Hipkiss explains the benefits for pharmaceutical manufacturers of using Prosonix’ sonocrystallisation technology.
Spotlight
  EU plan to add APIs to pollutant watch list could raise costsEuropean Commission plans to add three APIs to its list of water polluting chemicals could result in... |
Supplier Webinars
On demand Supplier Webinars
All supplier webinars
Latest news
On your radar
Globalisation
- China healthcare spending up despite economic fears, BD says
- FDA calls for more powers to adopt nationwide ePedigree
Lifecycle management
- Samsung and Quintiles' biosimilars JV teams with Biogen Idec
- Ongoing quality problems at injectables plant hurt Hospira in Q3
Counterfeiting
- Annual WHO meeting to tackle spread of substandard drugs
- FDA calls for more powers to adopt nationwide ePedigree
